Home › NDC Lookup › RxCUI directory › RxCUI 1001004

Pilocarpine hydrochloride 7.5 MG Oral Tablet — RxCUI 1001004

RxNorm drug concept · Semantic clinical drug
RxCUI 1001004 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1001004
Official namePilocarpine hydrochloride 7.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspilocarpine HCl 7.5 MG Oral Tablet
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)36,985 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pilocarpine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Eye drops are used for glaucoma, raised eye pressure or presbyopia, depending on the brand. Tablets treat dry mouth from head and neck radiation or Sjogr...
  • Eye drops go in the eye and tablets are swallowed. Schedules vary by product, so follow your prescriber and your label. For dry mouth, it can take weeks to know if the tablets are...
  • With tablets, sweating is the most common, along with nausea, runny nose, diarrhea and chills. Eye forms can blur your vision, especially at night. Call your doctor if effects are...
  • Use extra caution. Tablets should not be used with uncontrolled asthma. With controlled asthma, COPD, chronic bronchitis or significant heart disease, you would need close supervis...
📖 Read our full Pilocarpine guide →

🕸️ Concept Web — How Pilocarpine hydrochloride 7.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pilocarpine hydrochloride 7.5 MG Oral Tablet RxCUI 1001004

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pilocarpine 8328
    • Pilocarpine hydrochloride 235426
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Salagen 202959
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pilocarpine Oral Tablet 374421
    • Pilocarpine hydrochloride Oral Tablet 2647647
    • Pilocarpine Oral Product 1158736
    • Pilocarpine Pill 1158737
    • Pilocarpine hydrochloride Oral Product 2660743
    • Pilocarpine hydrochloride Pill 2661429
    • Pilocarpine Oral Tablet [Salagen] 369271
    • Pilocarpine hydrochloride Oral Tablet [Salagen] 2657048
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pilocarpine hydrochloride 7.5 MG SCDC · 1001003
  • Pilocarpine Oral Tablet SCDF · 374421
  • Pilocarpine hydrochloride Oral Tablet SCDFP · 2647647
  • Pilocarpine Oral Product SCDG · 1158736
  • Pilocarpine Pill SCDG · 1158737
  • Pilocarpine hydrochloride Oral Product SCDGP · 2660743
  • Pilocarpine hydrochloride Pill SCDGP · 2661429

Brand-Name Concepts

  • Pilocarpine hydrochloride 7.5 MG Oral Tablet [Salagen] SBD · 1001006
  • Pilocarpine hydrochloride 7.5 MG [Salagen] SBDC · 1001005
  • Pilocarpine Oral Tablet [Salagen] SBDF · 369271
  • Pilocarpine hydrochloride Oral Tablet [Salagen] SBDFP · 2657048
  • Salagen Oral Product SBDG · 1184765
  • Salagen Pill SBDG · 1184766
  • Salagen BN · 202959

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 1001004 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-2801-11 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0228-2801-11) Pilocarpine hydrochloride Actavis Pharma, Inc. 2011-09-13
00228-2837-11 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0228-2837-11) Pilocarpine hydrochloride Actavis Pharma, Inc. 2011-09-13
00527-1313-01 100 TABLET, FILM COATED in 1 BOTTLE (0527-1313-01) Pilocarpine Hydrochloride Lannett Company, Inc. 2005-10-14
00527-1407-01 100 TABLET, FILM COATED in 1 BOTTLE (0527-1407-01) Pilocarpine Hydrochloride Lannett Company, Inc. 2005-10-14
59212-0705-10 100 TABLET, FILM COATED in 1 BOTTLE (59212-705-10) Salagen Advanz Pharma (US) Corp. 2019-09-01
59212-0775-10 100 TABLET, FILM COATED in 1 BOTTLE (59212-775-10) Salagen Advanz Pharma (US) Corp. 2019-09-01
59651-0224-01 100 TABLET, FILM COATED in 1 BOTTLE (59651-224-01) Pilocarpine Hydrochloride Aurobindo Pharma Limited 2019-08-13
59651-0225-01 100 TABLET, FILM COATED in 1 BOTTLE (59651-225-01) Pilocarpine Hydrochloride Aurobindo Pharma Limited 2019-08-13
Observed labelers: Actavis Pharma, Inc. (2) · Advanz Pharma (US) Corp. (2) · Aurobindo Pharma Limited (2) · Lannett Company, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.